- Losers: Renalytix Plc (RNLX) -25%.
- CytomX Therapeutics (CTMX) -17% reports Q4 results.
- Acadia Pharmaceuticals (ACAD) -16% after schizophrenia treatment fails clinical trial.
- Power & Digital Infrastructure Acquisition II Corp (XPDB) -17%.
- ASLAN Pharmaceuticals Ltd (ASLN) -14%.
- On Holding AG (ONON) -11% after Q4 earnings release.
- Solidion Technology (STI) -11%.
- Kidpik Corp (PIK) -12%.
- Sonnet BioTherapeutics Holdings (SONN) -10%.
- FiscalNote Holdings (NOTE) -6% after Q4 earnings release.
- Semilux International Ltd. (SELX) -10%.
- Blade Air Mobility (BLDE) -10% after Q4 earnings release.
- Socket Mobile (SCKT) -8% announces Socket Cam advanced camera scanning support for react native.
- CERo Therapeutics Holdings (CERO) -7%.
- NextPlay Technologies (NXTP) -8%. received Nasdaq notice for listing non-compliance.
- Southwest Airlines Co (LUV) -7% on 2024 capacity reduction plan, citing Boeing issues.
- Safe and Green Development Corp (SGD) -5%.
- Amesite (AMST) -5% announces strategic five-year partnership to expand workforce development.
- Psyence Biomedical Ltd. (PBM) -7% issues shareholder letter recapping recent progress and outlining key future milestones.
- Ohmyhome Ltd (OMH) -6%.
- Alto Ingredients (ALTO) -7% after Q4 earnings release.
- PLDT (PHI) -6%.
- Brera Holdings (BREA) -5%.
- Amylyx Pharmaceuticals (AMLX) -6%.
- reAlpha Tech Corp. (AIRE) -5%.